Glaxo and Genmab drop IV version of MS immune drug
Glaxo and Genmab drop IV version of MS immune drug
GlaxoSmithKline PLC and Genmab A/S will end the development of an intravenous form of a drug intended to treat autoimmune diseases like lupus and multiple sclerosis, and focus on an injectable version.
The companies said an injectable version of Arzerra (ofatumumab) should be more convenient for patients and have fewer side effects. The drug can also be used to treat rheumatoid arthritis...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1854 Views
-
Last post by goellerc
-
- 0 Replies
- 1138 Views
-
Last post by ElliotB
-
- 3 Replies
- 5013 Views
-
Last post by NHE
-
- 5 Replies
- 14315 Views
-
Last post by gibbledygook
-
- 1 Replies
- 1567 Views
-
Last post by ElliotB
-
- 0 Replies
- 1057 Views
-
Last post by DIM
-
- 0 Replies
- 505 Views
-
Last post by NHE
-
- 0 Replies
- 1669 Views
-
Last post by NHE
-
- 1 Replies
- 3149 Views
-
Last post by Tif